Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

safety

  • You have access
    Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?
    CHIARA CICCARESE, ROBERTO IACOVELLI, SEBASTIANO BUTI, FRANCESCA PRIMI, SERENA ASTORE, FRANCESCO MASSARI, MIRIAM GRAZIA FERRARA, GIUSEPPE PALERMO, NAZARIO FOSCHI, VALERIO IACOVELLI, ERNESTO ROSSI, GIOVANNI SCHINZARI, PIERLUIGI BOVE, PIERFRANCESCO BASSI, EMILIO BRIA and GIAMPAOLO TORTORA
    Anticancer Research March 2022, 42 (3) 1487-1493; DOI: https://doi.org/10.21873/anticanres.15620
  • You have access
    Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI” study)
    ATHANASIOS ALEXOPOULOS, CHARISIOS KARANIKIOTIS, ALEXANDROS ARDAVANIS, IOANNIS BOUKOVINAS, PARISIOS MAKRANTONAKIS, CHRISTOS PAPADIMITRIOU, ATHANASIOS ATHANASIADIS, ANASTASIOS BOUTIS, STYLIANOS GIASSAS, STYLIANOS KAKOLYRIS, GEORGIOS KOUMAKIS, KONSTANTINOS PAPAZISIS, ADAMANTIA PSYRRI, NIKOLAOS ZIRAS, SOFIA BAKA, NIKOLAOS KENTEPOZIDIS and VASILIKI MICHALAKI
    Anticancer Research February 2022, 42 (2) 1031-1041; DOI: https://doi.org/10.21873/anticanres.15564
  • You have access
    The Efficacy and Safety of Trifluridine/Tipiracil Treatment for Elderly Patients With Metastatic Colorectal Cancer in a Real-world Setting
    MASATSUNE SHIBUTANI, WANG EN, YUKI OKAZAKI, SHINICHIRO KASHIWAGI, TATSUNARI FUKUOKA, YASUHITO ISEKI, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research December 2021, 41 (12) 6211-6216; DOI: https://doi.org/10.21873/anticanres.15440
  • You have access
    Pooled-analysis of Lipegfilgrastim Effectiveness and Safety Among Patients With Blood Malignancies in the Real-world Setting
    RUTH PETTENGELL, THOMAS WOLFF, THOMAS GOEHLER and NICOLA CASCAVILLA
    Anticancer Research January 2021, 41 (1) 347-354; DOI: https://doi.org/10.21873/anticanres.14782
  • You have access
    Recurrence-free Survival and Safety of Imatinib in Patients With Gastrointestinal Stromal Tumour (GIST) in Greece
    IOANNIS BOUKOVINAS, ATHANASIOS KOTSAKIS, NIKOLAOS ANDROULAKIS, GERASIMOS ARAVANTINOS, VASILIKI MICHALAKI, CHRISTOS CHRISTODOULOU, ANTONIOS AVGERINOS, CHRISTOS PAPANDREOU, VASILIKI SIDIROPOULOU, OLGA KOUSIDOU and PARIS KOSMIDIS
    Anticancer Research January 2020, 40 (1) 435-441; DOI: https://doi.org/10.21873/anticanres.13971
  • You have access
    Safety Evaluation of Autologous Tissue Vaccine Cancer Immunotherapy in a Canine Model
    RACHEL A. CROSSLEY, ALYSSA MATZ, TERRY DEW, ASHLEY KALINAUSKAS, NICOLE FAUCETTE, BRAD POFF, LAWRENCE K. SILBART and MARK A. SUCKOW
    Anticancer Research April 2019, 39 (4) 1699-1703; DOI: https://doi.org/10.21873/anticanres.13275
  • You have access
    Significance of Age in Japanese Patients Receiving Sunitinib as First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: Comparative Assessment of Efficacy and Safety between Patients Aged <75 and ≥75 Years
    HIDEAKI MIYAKE, RYOTA AKI, YUTO MATSUSHITA, KEITA TAMURA, DAISUKE MOTOYAMA, TOSHIKI ITO, TAKAYUKI SUGIYAMA and ATSUSHI OTSUKA
    Anticancer Research June 2018, 38 (6) 3593-3599; DOI: https://doi.org/10.21873/anticanres.12633
  • You have access
    Safety of Simultaneous Bilateral Pulmonary Resection for Metastatic Lung Tumors
    TAICHI MATSUBARA, GOUJI TOYOKAWA, FUMIHIKO KINOSHITA, NAOKI HARATAKE, YUKA KOZUMA, TAKAKI AKAMINE, SHINKICHI TAKAMORI, FUMIHIKO HIRAI, TETSUZO TAGAWA, TATSURO OKAMOTO and YOSHIHIKO MAEHARA
    Anticancer Research March 2018, 38 (3) 1715-1719;
  • You have access
    Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer
    TSUTOMU TAKASHIMA, HIDEMI KAWAJIRI, TAKEO NISHIMORI, SEIKA TEI, SHIGEHIKO NISHIMURA, SHIGEHITO YAMAGATA, SHINYA TOKUNAGA, YOKO MIZUYAMA, TAKESHI SUNAMI, KENJI TEZUKA, KATSUMI IKEDA, YOSHINARI OGAWA, SHINICHIRO KASHIWAGI, SATORU NODA, NAOYOSHI ONODA, TETSURO ISHIKAWA, SHINZOH KUDOH, MINORU TAKADA, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research January 2018, 38 (1) 379-383;
  • You have access
    Efficacy and Safety of Neoadjuvant Chemoradiotherapy Following Esophagectomy with Japanese-style Extended 3-Field Lymphadenectomy for Thoracic Esophageal Cancer
    SATORU MOTOYAMA, YUSUKE SATO, TOMOHIKO SASAKI, AKIYUKI WAKITA, YUTA KAWAKITA, JIAJIA LIU, YUSHI NAGAKI, HAJIME SAITO, KAZUHIRO IMAI, HAYATO KONNO, KAORI T. MIZUSAWA and YOSHIHIRO MINAMIYA
    Anticancer Research October 2017, 37 (10) 5837-5843;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire